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Abstract  
Restrictive cardiomyopathy (RCM) in children is associated with a greater risk of embolic stroke 
than are other congenital heart diseases. After diagnosis, 50% of children with RCM die within 2 
years without heart transplantation. As such, all RCM patients are placed on the heart 
transplantation list and must wait for an appropriate heart for transplantation. Every type of embolic 
stroke can occur while waiting for a donor heart; therefore, the cardiovascular team must initiate 
antithrombotic therapy at time RCM is diagnosed. Some pediatric RCM patients experience embolic 
stroke (50% are the cerebral type) despite antithrombotic therapy, including acetylsalicylic acid, 
warfarin, and heparine. Neurosurgeons working in hospitals that perform organ transplantation 
expect to see RCM cases with restrictive large cerebral infarct. We think that decompressive 
craniectomy should be performed as soon as possible after determining the clinical condition of any 
patient with RCM and a large right middle cerebral artery (MCA) infarct.  
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
The annual incidence of restrictive 
cardiomyopathy (RCM) is approximately 0.035 per 
100,000 children in Australia and the US [1]. Biatrial 
enlargement, relatively normal systolic function, and 
poor ventricular filling due to restrictive physiology are 
characteristic of this cardiac disorder [2].
 
 Intracardiac 
thrombus and embolic thrombus  occur in 0%-42%and 
12%-33% of children with RCM, respectively [3-7].  
Cardiac surgeons and cardiologists favor performing 
cardiac transplantation as soon as possible following 
the diagnosis of RCM due to poor prognosis and poor 
response to medical therapy, and the risk of rapidly 
progressing elevated pulmonary vascular resistance 
and sudden death. Moreover, the risk of embolism is 
high and cerebrovascular embolic events account for 
50% of all embolic events in RCM patients [3, 5, 8, 9].  
Cardiac transplantation should be performed as soon 
as possible in patients with RCM experiencing 
embolic events.  Following the diagnosis of RCM 
>50% of patients die within 2 years without cardiac 
transplantation [3, 5, 8, 9]. Neurosurgeons prefer 
performing decompressive craniectomy soon after 
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extensive middle cerebral artery (MCA) region infarct, 
even in patients without midline shift or herniation, 
because development of midline shift and extensive 
edema eventually occur due to ischemia and energy 
failure [10-12].  A delay >48 h can result in a 
vegetative state or death in patients with an occluded 
MCA. As such, decompressive craniectomy should be 
performed within 48 h of an embolic event [10-12].  A 
Medline search of the English-language literature 
conducted in February 2013 using various 
combinations of 10 key words regarding cardiac 
transplantation following decompressive craniectomy 
in a patient with RCM and total occlusion of the right 
MCA did return any results. To the best of our 
knowledge the first such case is presented herein. 
 
Case Report 
A 16-year-old male RCM patient (height: 160 
cm; weight: 54 kg) with left dominant hemisphere was 
hospitalized for cardiac transplantation. Cardiac 
surgeons and pediatric cardiologists (CSPS) had 
diagnosed his disease in 2008, at which time he was 
placed on the waiting list for heart transplantation and 
antithrombotic therapy (acetylsalicylic acid 300 mg in 
a day) was initiated. Acetylsalicylic acid treatment was 
stopped and low-molecular-weight heparin (LMWH) 
was started during the cardiac transplantation 
preoperative period. While waiting for cardiac 
transplantation in the cardiovascular surgery 
department he experienced numbness and tingling in 
his left arm and left leg. The cardiovascular surgeons 
then consulted the patient to the neurology and 
neurosurgery departments overnight.  
 
Figure 1: Axial CT shows a hyperdense MCA and subtle low density 
in the territory of the right MCA; the right Sylvian cistern is not 
observed. 
 
Cranial CT (CCT) showed early abnormal 
findings - hemispheric sulcus effacement in the right 
cerebral hemisphere, loss of a hypodense 
appearance of the right Sylvian cistern, and  a 
hyperdense right MCA (Fig. 1) - and his Glasgow 
Coma Scale (GCS) score was 15/15, with no loss of 
power. Diffusion weighted MRI (DW-MRI), apparent 
diffusion coefficient (ADC) mapping, and magnetic 
resonance angiography (MRA) were performed 2 
hours after the stroke; which showed complete 
occlusion of the right MCA via MRA (Fig. 2), a bright 
right MCA acute infarction via DW-MRI (Fig. 3), and a 
low signal in the same location via the corresponding 
ADC map (Fig. 4), confirming the presence of 
restricted diffusion in the territory supplied by the right 
MCA, but no midline shift.  
 
Figure 2: Axial DW-MRI shows a bright right MCA acute infarction.  
 
Approximately 27 hours later, the patient 
developed left sided hemiplegia, and his GCS score 
dropped from 15/15 to 12/15. We performed CCT 
again (Fig. 5), which showed an 11-mm midline shift 
from the right to the left and a hypodense appearance 
of the region supplied by the right MCA. Once we 
determined that his GCS score was 12/15, we started 
rapid mannitol infusion while transferring of the patient 
to the surgical suite. We then performed a large right 
frontotemporoparietal craniectomy using a high-speed 
drill in order to decompress the cerebrum. Next, we 
opened the duramater; we observed no pulsation of 
the cerebrum, which was edematous and much 
harder than usual. We did not close the duramater 
with stiches, but covered the duramater to the 
cerebrum. The scalp was then closed with sutures. 
Lastly, we incised the skin over the left lower 
abdominal quadrant and arranged a place below the 
skin and above the muscle fascia of this region and 
inserted the bone that was removed during 
craniectomy.  
The time from the onset of stroke to 
decompression was about 28 hours. Post surgery the 
patient remained intubated and on ventilator support, 
Case Report 
_______________________________________________________________________________________________________________________________ 
_______________________________________________________________________________________________________________________________ 
  476                                                                                                                                                                                                                     http://www.mjms.mk/ 
http://www.id-press.eu/mjms 
 
and was transferred to the ICU. The patient’s arterial 
blood gas parameters were as follows: pH: 7.42; 
pCO2: 39 mmHg; pO2: 93 mmHg; HCO3: 14 mEQ L O2 
saturation: 99%, confirming that his status was stable. 
 
Figure 3: The correspondingADC map shows low signal intensity  
on  the right side,location, confirming the presence of restricted 
diffusion. 
 
The ventilator was set to SIMV mode and Diprivan
®
 
(propofol) 250 mg h and high-dose mannitol infusion 
was started. After 24 hours of ventilation we stopped 
Diprivan® and mannitol, and 1 hours later we 
extubated the patient. He was able to move his left leg 
and could raise it slightly when asked, and he was 
cooperative, but could not move his left arm hand 2 
hours post extubation.  
 
Figure 4: MRA frontal view shows non-visualization of the right 
MCA. 
 
The patient began physiotherapy 4
th
 day of 
post decompressive craniectomy. In the 
physiotherapy department the patient was fully 
conscious, oriented, and communicated well. CCT 
performed on 4
th
 day of the  craniectomy showed no 
edema or midline shift, but did show a large cystic 
encephalomalacic region previously supplied by the 
right MCA (Fig. 6). The patient underwent daily 
physiotherapy for his chest and limbs, and intensive 
exercise for his left hand and left leg. He improved 
steadily, and he was able to walk and 32
nd 
day
 
 of the  
surgery without assistance and began to move his left 
arm and forearm.  But he still could not move his left 
hand or fingers.   
 
Figure 5: Axial CT shows a large low-density infarction in the region 
supplied by the right MCA, midline shift from right to left, and closing 
of the right lateral ventricle due to increased intracranial pressure. 
 
The patient was recovering well and 42
nd
 day 
of post decompressive craniectomy, so we performed 
cranioplasty and used the bone that was inserted in 
his abdomen. Three days later,   we performed CCT, 
and it  showed  the bone that was replaced and the 
encephalomalasic region previously supplied by the 
right MCA, but no midline shift or other pathological 
signs (Fig. 7). Following his stroke, the cardiovascular 
team had removed the patient from the cardiac 
transplantation wait list due to his clinical condition, 
but his recovery was sufficient to persuade them to 
again place him on the list.  
 
Figure 6: Axial CT shows the large cystic encephalomalacic region 
that was supplied by the right MCA before the embolic stroke, and 
no signs of elevated intracranial pressure. Both lateral ventricles 
appear symmetrical and there is no midline shift. In addition, the 
defect in the craniectomy region is seen. 
 
The patient was discharged with prescriptions 
for physiotherapy and oral antiepileptic medicine and 
subcutaneous LMWH 1 mg/kg/d. A donor was 
eventually located for the patient and the 
cardiovascular team successfully transplanted a heart 
on 28 October 2010. The patient was discharged after 
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his recovery with immunosuppressive and 
antithrombotic therapy, including acetylsalicylic acid 
and clopidogrel. At the time this report was written (28 
months post transplantation), the patient was 
attending high school, playing soccer (despite his 
mother’s objection), and was able to raise his left arm 
as high as his head, but could not use his left hand or 
fingers.  
 
Figure 7: Axial CT appears similar to the figure 6, but does show 
the bone that was replaced during cranioplasty. 
 
Discussion 
Cerebrovascular stroke accounts for 50% of 
all embolic events in children with RCM, whether or 
not they have had intracardiac thrombus [3-7]. 
 
Children with RCM are at risk of thrombus formation 
due to turbulent blood flow and blood stasis - 
consequences of the contours of a dilated atrium, in 
terms of blood flow mechanics [3-7].    
In addition, an abnormal heart rhythm causes 
even greater turbulence and may also cause a 
thrombus to embolize. As such, antithrombotic 
therapy should be initiated at the time RCM is 
diagnosed in children due to the high risk of 
embolism, but no comparative study has reported the 
effectiveness of antiplatelet therapy against vitamin K 
antagonists in children with RCM [3-7].    Nonetheless, 
any child with RCM that has had an embolic stroke 
should be given anticoagulant therapy instead of 
antiplatelet therapy in order to prevent further embolic 
strokes, and should be immediately placed on a 
transplant wait list [5, 7, 8].  
Moreover, the sequelae of embolic strokes 
can preclude heart transplantation in children with 
RCM. Cardiac surgeons and pediatric cardiologists 
diagnosed the presented patient’s disease in 2008 
and placed him on the wait list for heart 
transplantation. They initiated antithrombotic therapy 
using acetylsalicylic acid 300 mg per day. When he 
was consulted to our department we decided to 
follow-up via observation for a while because his 
examination showed minimal loss of strength on the 
left side and no cognitive dysfunction. We thought that 
giving subcutaneous LMWH would be preventive, and 
it would not hinder in case of acute surgical 
intervention necessity would come up for the patient, 
and we did not start mannitol treatment at the 
beginning of the stroke. Clinical investigations 
reported that use of LMWH for acute ischemic stroke 
in children is safe [13-17], but no comparative study 
showing the efficacy or superiority of these drugs 
including acetylsalicylic acid,warfarin,heparine and 
ultra-fractionated  heparine [18-21]. 
We decided that thrombolysis was not an 
appropriate treatment for the presented patient 
because intra-arterial use of thrombolytic treatment is 
not recommended for children outside of clinical trials 
due to the high risk of complications, and due to the 
lack of consensus on the use of thrombolytic 
treatment in adolescents with acute ischemic stroke 
[22-24]. We promptly performed decompressive 
craniectomy, because delaying the procedure and 
performing it with patients after their clinical condition 
declines negatively affects functional rehabilitation in 
patients with right MCA occlusion and can even result 
in a post surgical vegetative state [25-27]. The 
decision to perform decompressive craniectomy in 
cases of left MCA occlusion due to embolic stroke is 
more compelling for neurosurgeons than in cases of 
right MCA occlusion in patients with a dominant left 
hemisphere [25-27]. If the presented RCM patient had 
had an occluded left MCA, we would not have 
performed the surgery. Moreover, patients with RCM 
and an occluded right MCA have a greater risk than 
those without RCM of shorter postoperative survival 
and lack of independent functioning following cranial 
surgery. We think that a multidisciplinary approach is 
essential for the treatment of patients with RCM and 
right MCA occlusion. Once right MCA occlusion is 
verified via CCT or DW-MRI, ADC, and MRA, 
neurosurgeons should perform decompressive 
craniectomy without waiting for clinical deterioration 
and the development midline shift (based on cranial 
MRI or CCT) in order to prevent further complications, 
including subfalcine and transtentorial herniation, and 
brainstem hemorrhage.  
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